Literature DB >> 3235282

The Beck Depression Inventory as a screening device for major depression in renal dialysis patients.

J L Craven1, G M Rodin, C Littlefield.   

Abstract

Self-report measures of depressive symptoms have been frequently employed in medically ill samples despite the lack of information regarding their psychometric properties in these subjects. We have examined the agreement of the Beck Depression Inventory (BDI) with DSM-III diagnoses of depression in a sample of renal dialysis subjects (n = 99). A threshold of greater than or equal to 15 on the BDI produced optimal sensitivity (.92), negative predictive value (.99), and maximized Youden's index of validity (.72) for the use of the BDI as a screening device for depressive syndromes in dialysis patients. Higher BDI threshold levels decreased the sensitivity of the measure but did not produce a clinically meaningful increase in the positive predictive value.

Entities:  

Mesh:

Year:  1988        PMID: 3235282     DOI: 10.2190/m1tx-v1ej-e43l-rklf

Source DB:  PubMed          Journal:  Int J Psychiatry Med        ISSN: 0091-2174            Impact factor:   1.210


  56 in total

1.  Elevated depressive affect is associated with adverse cardiovascular outcomes among African Americans with chronic kidney disease.

Authors:  Michael J Fischer; Paul L Kimmel; Tom Greene; Jennifer J Gassman; Xuelei Wang; Deborah H Brooks; Jeanne Charleston; Donna Dowie; Denyse Thornley-Brown; Lisa A Cooper; Marino A Bruce; John W Kusek; Keith C Norris; James P Lash
Journal:  Kidney Int       Date:  2011-06-01       Impact factor: 10.612

2.  Depressive symptoms and dietary adherence in patients with end-stage renal disease.

Authors:  Amani A Khalil; Susan K Frazier; Terry A Lennie; B Peter Sawaya
Journal:  J Ren Care       Date:  2011-03

3.  Performance of depression rating scales in patients with chronic kidney disease: an item response theory-based analysis.

Authors:  Marisa Toups; Thomas Carmody; Madhukar H Trivedi; A John Rush; S Susan Hedayati
Journal:  Gen Hosp Psychiatry       Date:  2016-07-25       Impact factor: 3.238

Review 4.  A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease.

Authors:  S Susan Hedayati; Venkata Yalamanchili; Fredric O Finkelstein
Journal:  Kidney Int       Date:  2011-10-19       Impact factor: 10.612

5.  Depression, stress, and quality of life in persons with chronic kidney disease: the Heart and Soul Study.

Authors:  Michelle C Odden; Mary A Whooley; Michael G Shlipak
Journal:  Nephron Clin Pract       Date:  2005-12-07

6.  Psychosocial intervention improves depression, quality of life, and fluid adherence in hemodialysis.

Authors:  Daniel Cukor; Nisha Ver Halen; Deborah Rosenthal Asher; Jeremy D Coplan; Jeremy Weedon; Katarzyna E Wyka; Subodh J Saggi; Paul L Kimmel
Journal:  J Am Soc Nephrol       Date:  2013-10-10       Impact factor: 10.121

7.  Treatment of depression and poor mental health among patients receiving maintenance dialysis: are there options other than a pill or a couch?

Authors:  Michael J Fischer; Anna C Porter; James P Lash
Journal:  Am J Kidney Dis       Date:  2013-05       Impact factor: 8.860

8.  Prevalence of major depressive episode in CKD.

Authors:  S Susan Hedayati; Abu T Minhajuddin; Robert D Toto; David W Morris; A John Rush
Journal:  Am J Kidney Dis       Date:  2009-06-03       Impact factor: 8.860

9.  Validation of depression screening scales in patients with CKD.

Authors:  S Susan Hedayati; Abu T Minhajuddin; Robert D Toto; David W Morris; A John Rush
Journal:  Am J Kidney Dis       Date:  2009-06-03       Impact factor: 8.860

10.  Effects of 6-times-weekly versus 3-times-weekly hemodialysis on depressive symptoms and self-reported mental health: Frequent Hemodialysis Network (FHN) Trials.

Authors:  Mark L Unruh; Brett Larive; Glenn M Chertow; Paul W Eggers; Amit X Garg; Jennifer Gassman; Maria Tarallo; Fredric O Finkelstein; Paul L Kimmel
Journal:  Am J Kidney Dis       Date:  2013-01-15       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.